Prolonged survival after single lung transplantation for pulmonary hypertension secondary to systemic lupus erythematosus

Journal of the Chinese Medical Association

Volumn 67, Issue 5, 2004, Pages 248-251

  Chen, Li Ju ^a,b   Chang, Hung Chou ^a   Lu, Ling Ying ^a   Tseng, Jui Cheng ^a   Hu, Jui Chieh ^a   Kau, Chien Kai ^a   Cheng, He Hsiung ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE   (Taiwan)

Author keywords

Pulmonary hypertension; Single lung transplantation; Systemic lupus erythematosus

Indexed keywords

AMLODIPINE; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BAKTAR; CEFTAZIDIME; CLINDAMYCIN; COTRIMOXAZOLE; CYCLOSPORIN; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYCHLOROQUINE; LABETALOL; METHYLPREDNISOLONE; PREDNISOLONE; PROSTAGLANDIN E1; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BACTERIAL INFECTION; BRONCHOSCOPY; CASE REPORT; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; FEMALE; FORCED EXPIRATORY VOLUME; HEART CATHETERIZATION; HUMAN; LEUKOPENIA; LIFESPAN; LUNG ARTERY PRESSURE; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; LUNG VENTILATION PERFUSION RATIO; PNEUMOCYSTOSIS; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG TRANSPLANTATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 4043171371     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Sanchez O, Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary hypertension secondary to connective tissue disease. Thorax 1999;54:237-7.
2. Horn CA. Pulmonary hypertension and autoimmune disease. Chest 1993;104:279-80.
3. Mendeloff EN, Meyers BF, Sundt TM, Guthrie TJ, Sweet SC, de L, et al. Lung transplantation for pulmonary vascular disease. Ann Thorac Surg 2002;73:209-19.
4. Levy RD, Guerraty AJ, Yacoub MH, Loertscher R. Prolonged survival after heart-lung transplantation in systemic lupus erythematosus. Chest 1993;104:1903-5.
5. Frist WH, Carmichael LC, Loyd JE, Merrill WH, Stewart JR, Biggs VJ, et al. Transplantation for pulmonary hypertension. Transplant Proc 1993;25:1159-61.
6. Pasque MK, Trulock EP, Cooper JD, Triantafillou AN, Huddleston CB, Rosenbloom M, et al. Single lung transplantation for pulmonary hypertension: Single institution experience in 34 patients. Circulation 1995;92:2252-8.
7. Bando K, Armitage JM, Paradis IL, Keenan RJ, Hardesty RL, Konishi H, et al. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 1994;108:1056-65.
8. Frist WH, Loyd JE, Merrill WH, Stewart JR, Dummer JS, Hoff SJ. et al. Single lung transplantation: a temporal look at rejection, infection, and survival. Am Surg 1994;60:94-102.